kneat.com (TSE:KSI) has released an update.
Kneat.com has partnered with Körber Pharma Consulting, a leader in life sciences technology, to enhance Kneat’s market reach by enabling Körber to resell and implement Kneat Gx, a platform for digitizing validation and quality processes in the life sciences industry. Körber, with over 125 years of experience and a large global footprint, plans to integrate Kneat Gx with its own MES suite, aiming to improve manufacturing efficiency and validation for its customers. The partnership is set to further digital transformation in the life sciences sector, promising enhanced safety and efficiency in developing and delivering products.
For further insights into TSE:KSI stock, check out TipRanks’ Stock Analysis page.
